|
|
- 2016
健脾益肾排毒方对CKD4脾肾气虚患者eGFR及中医证候的影响
|
Abstract:
摘要 目的:观察健脾益肾排毒方对CKD4期患者eGFR及中医证候的影响.方法:将80例脾肾气虚患者分为对照组与治疗组各40例.对照组给予饮食营养、控制血压、纠正贫血、改善钙磷代谢紊乱、调节酸碱代谢平衡等常规治疗.治疗组在上述基础上予健脾益肾排毒方水煎剂,每日1剂,分2次服.分别检测患者治疗后2周、4周、3个月、6个月血肌酐、血尿素氮,并计算其相应GFR及中医证候积分.最终对照组患者有33例、治疗组有34例完成试验.结果:治疗组和对照组肾功能在治疗后表现为Scr和BUN出现短暂小幅度上升,随后缓慢下降,eGFR呈相反趋势,至治疗后3个月,无统计学差异.在治疗后6个月,治疗组血肌酐及血尿素氮均有所降低,而治疗组eGFR有所升高,与对照组比较,均有统计学差异(P<0.05).治疗过程中,2组患者中医证候积分呈进行性下降,治疗后6个月,治疗组与对照组比较,有统计学差异(P<0.05).结论:健脾益肾排毒方能改善CKD4期脾肾气虚患者肾功能及临床症状,在治疗6个月后可使eGFR升高,中医证候积分下降.
| [1] | 郑筱英.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:164. |
| [2] | PATEL M V,GUPTA S N,PATEL N G. Effects of Ayurvedic treatment on 100 patient of chronic renal failure(other than diabetic nephropathy)[J].Ayu,2011,32(4):483. |
| [3] | DILLON J J.The quantitative relationship between treated blood pressure and progression of diabetic renal disease[J]. American Joural of Kidney Diseases,1993,22(6):798-802. |
| [4] | PEI Y, CATTRAN D, GREENWOOD C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis[J]. Kidney International, 1992,42(4):960-966. |
| [5] | MASSY Z A, KHOA T N, LACOUR B,et al. Dyslipidaemia and the progression of renal disease in chronic renal failure patients[J]. Nephrology Dialysis Transplantation, 1999,14(10):2392-2397. |
| [6] | 王海燕,王 梅.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003:36. |
| [7] | LEVEY A S, STEVENS L A, SCHMID C H, et al. A new equation to estimate glomerular filtration rate[J].Ann intern med,2009,150(9):604-612. |
| [8] | 中华中医药学会肾病分会.慢性肾衰的诊断、辨证分型和疗效评定(试行方案)[J].上海中医药杂志,2006,40(8):9. |
| [9] | HANNEDOUCHE T, ALBOUZE G, CHAUVEAU P, et al. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure[J]. American Journal of Kidney Diseases, 1993,21(5 Suppl 2):131-137. |
| [10] | YIP J W, JONES S L, WISEMAN M J, et al. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study[J]. Diabetes,1996,45(12):1729-1733. |
| [11] | BABOOLAL K, EVANS C, MOORE R H.Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease[J]. American Journal of Kidney Diseases, 1998,31(6):971-977. |
